Tech Company Financing Transactions
InnoPharma Funding Round
Athyrium Opportunities Fund invested in a $20 million capital raise for InnoPharma. The financing round was announced by the company on 11/14/2013.
Transaction Overview
Company Name
Announced On
11/14/2013
Transaction Type
Debt
Amount
$20,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds from the loan will be used to further develop a variety of injectable and ophthalmic-dosage drugs.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
10 Knightsbridge Road
Piscataway, NJ 08854
USA
Piscataway, NJ 08854
USA
Phone
Website
Email Address
Overview
InnoPharma, Inc. develops niche generic and specialty pharmaceutical/bio-pharmaceutical products in sterile dosage forms, and out-licenses to pharmaceutical marketing companies for commercialization.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Navneet Puri
Chief Financial Officer
John Deighan
Chief Operating Officer
Sriram Ramanathan
Chief Scientific Officer
Satish Pejaver
Browse more venture capital transactions:
Prev: 11/14/2013: Ubiquity Global Services venture capital transaction
Next: 11/14/2013: HelloWallet venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on tech company VC transactions. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs